EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension

Yongneng Zhang iD, Sébastien Bonnet iD, Steeve Provencher iD, Jiyuan Piao iD, Alois Haromy iD, Yongsheng Liu, Yuan-Yuan Zhao, Sandra Breuils-Bonnet, Sarah-Eve Lemay iD, Dawn E Bowles, Michelle Mendiola Pla iD, Gopinath Sutendra iD und 1 weitere

Circulation · 12.05.2026 · 153 (19) · 1494-1515

DOI: 10.1161/circulationaha.125.078674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 12.05.2026. Verfasst von Yongneng Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Cardiology), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada (Y.Z., J.P., A.H., Y.L., Y.-…. Hauptthemen laut MEDLINE: Uncoupling Protein 2, Hypertension, Pulmonary, Ventricular Dysfunction, Right, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Right ventricular failure drives both morbidity and mortality in pulmonary arterial hypertension (PAH), but the mechanism of transition from compensated right ventricle (cRV) to decompensated RV (dRV) is unknown, and some PAH patients develop dRV faster than others. METHODS: We explored the role of RV cardiac myofibroblasts (cMFBs) on this transition utilizing 2 rat models: monocrotaline (MCT) versus the less inflammatory pulmonary artery banding (PAB); and 3 patient cohorts (n=81) of PAH versus group 2 pulmonary hypertension (PHT-2). We hypothesized that loss of UCP2 (uncoupling protein 2), critical for mitochondrial calcium (mCa ++ ) regulation and cardiac fibroblasts (cFBs) differentiation to cMFBs, is associated with dRV; and that a loss-of-function UCP2 single nucleotide polymorphism (SNP; rs659366) may predict dRV in human PAH. RESULTS: We separated rat cRV from dRV based on catheterization and echocardiographic criteria and found a significant increase in cMFBs from MCT but not PAB RV (which decompensated much later than MCT RV). In isolated hearts, MCT RV contractility was lower in dRV but not in isolated cardiomyocytes (CMs), pointing to a non-CM cause. Mitochondrial respiration was lower in MCT dRV cMFBs than in control and cRV cFBs but increased in MCT–RV CMs. mCa ++ was progressively decreased from normal to MCT–cRV to dRV cMFBs, and the same was true for c(M)FBs (but not CMs) UCP2. Tumor necrosis factor alpha (TNF-α) decreased UCP2 mRNA/protein levels in RV cFBs but not RV CMs. In human PAH, but not PHT-2, dRVs had more cMFBs and less UCP2 than control and cRVs. Decreased UCP2 levels and rs659366 were associated with worse RV performance (tricuspid annular plane systolic excursion and cardiac index), even among patients with similar mean pulmonary arterial pressure. CONCLUSIONS: Our data suggest that a change of cell identity (cFBs to cMFBs) in the RV is a driver of RV decompensation. TNF-α or rs659366 is a potential biomarker for early RV decompensation in PAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uncoupling Protein 2Hypertension, PulmonaryVentricular Dysfunction, RightPolymorphism, Single NucleotideMyofibroblastsHeart FailureAnimalsHumansRatsMaleFemaleGenetic Predisposition to DiseaseRats, Sprague-DawleyMiddle AgedDisease Models, AnimalCells, Cultured

Stichwörter der Autor:innen

calciumheart failurehypertension, pulmonaryhypertrophy, right ventricularmyofibroblaststumor necrosis factor-alphauncoupling protein 2

Substanzen

Uncoupling Protein 2UCP2 protein, humanUcp2 protein, rat

Autor:innen und Institutionen

  • Department of Medicine (Cardiology), Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada (Y.Z., J.P., A.H., Y.L., Y.-Y.Z., G.S., E.D.M.).
  • Pulmonary Hypertension and Vascular Biology Research Group CRIUCPQ, Department of Medicine, Laval University, Quebec, Canada (S.B., S.P., S.B.-B., S.-E.L.).
  • Institute for Lung Health, German Center for Lung Research (DZL), Cardio-Pulmonary Institute, Justus Liebig University Giessen, Giessen, Germany (S.B.).
  • Department of Surgery, Duke University Medical Center, Durham, NC(D.E.B., M.M.P.).

ORCID-Profile: Yongneng Zhang, Sébastien Bonnet, Steeve Provencher, Jiyuan Piao, Alois Haromy, Sarah-Eve Lemay, Michelle Mendiola Pla, Gopinath Sutendra, Evangelos D Michelakis

Zitieren

APA

Zhang, Y., Bonnet, S., Provencher, S., Piao, J., Haromy, A., Liu, Y., Zhao, Y. Y., Breuils-Bonnet, S., Lemay, S. E., Bowles, D. E., Mendiola Pla, M., Sutendra, G., & Michelakis, E. D. (2026). Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension. Circulation, 153(19), 1494-1515. https://doi.org/10.1161/circulationaha.125.078674

Vancouver

Zhang Y, Bonnet S, Provencher S, Piao J, Haromy A, Liu Y, et al. Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension. Circulation. 2026;153(19):1494-1515. doi:10.1161/circulationaha.125.078674

BibTeX
@article{Zhang2026,
  author = {Zhang, Yongneng and Bonnet, Sébastien and Provencher, Steeve and Piao, Jiyuan and Haromy, Alois and Liu, Yongsheng and Zhao, Yuan-Yuan and Breuils-Bonnet, Sandra and Lemay, Sarah-Eve and Bowles, Dawn E and Mendiola Pla, Michelle and Sutendra, Gopinath and Michelakis, Evangelos D},
  title = {Critical Contribution of Cardiac Myofibroblasts in Right Ventricular Failure and the Role of UCP2 SNPs in the Predisposition to RV Decompensation in Pulmonary Arterial Hypertension},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {19},
  pages = {1494--1515},
  doi = {10.1161/circulationaha.125.078674}
}
Kostenlos starten →